Founders Fund V Management LLC bought a new position in shares of Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 480,708 shares of the company’s stock, valued at approximately $764,000. Cyclo Therapeutics accounts for 80.8% of Founders Fund V Management […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 331,200 shares, an increase of 83.3% from the December 15th total of 180,700 shares. Currently, 3.1% of the company’s stock are short sold. […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 133,100 shares, a decrease of 31.3% from the August 31st total of 193,800 shares. Based on an average daily volume of 56,400 shares, the short-interest ratio […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH) Sees Large Decline in Short Interest kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a large increase in short interest in the month of July. As of July 15th, there was short interest totalling 94,400 shares, an increase of 93.8% from the June 30th total of 48,700 shares. Based on an average daily trading volume, of 153,200 […]